Startup profile for SafeRide Health: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

SafeRide Health funding, valuation and investors

Technology-first non-emergency medical transportation (NEMT) platform for Medicaid, Medicare Advantage, and providers.

Keep track of SafeRide Health

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Series C

Amount not disclosed · October 2023

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

Not publicly disclosed

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

growth · San Antonio, TX

Investors in latest funding

Lead: Sands Capital

Other: Healthworx (CareFirst) , SCAN Group , Fresenius Medical Ventures , Bonfire Ventures

Sources: latest funding Last verified: 2026-07-26

Overview

SafeRide Health connects Medicaid, Medicare Advantage, and provider program members to non-emergency medical transportation via a technology platform and vetted nationwide carrier network. Founded 2016; HQ San Antonio. Raised Series A led by Fresenius Medical Ventures (2019), Series B (2021), and Series C led by Sands Capital (Oct 2023) with Healthworx (CareFirst), SCAN Group, and earlier investors including Fresenius Medical Ventures and Bonfire Ventures. Stage maps to growth after Series C.

Why SafeRide Health is interesting

San Antonio healthcare access scale-up: Series C led by Sands Capital (Oct 2023) to digitize the $10B+ NEMT market — HQ expansion in SA while serving national MA/Medicaid programs.

Product & use cases

Payer/provider platform for booking, routing, and managing NEMT with real-time visibility across a multimodal transportation network.

  • Medicare Advantage plans reducing missed appointments
  • Medicaid brokers modernizing NEMT delivery
  • Health systems coordinating patient transport to dialysis and specialty care

Key facts

  • Series C (Oct 2023): led by Sands Capital; Healthworx and SCAN among participants
  • HQ: San Antonio — new HQ opened Dec 2024 (company PR)
  • Serves large Medicaid / Medicare Advantage / provider NEMT programs nationally
  • Thesis: tech-brokered NEMT vs. opaque legacy brokerage

Funding history (newest first)

Series C

2023-10
  • Sands Capital (lead)
  • Healthworx (CareFirst) (participant)
  • SCAN Group (participant)
  • Fresenius Medical Ventures (participant)
  • Bonfire Ventures (participant)

Source: https://www.businesswire.com/news/home/20231005891525/en/SafeRide-Health-Continues-Growth-in-Improving-Access-to-Life-Sustaining-Care-with-Series-C-Funding

Competitive landscape

Edge: Technology-first NEMT with AI/self-service tools versus legacy transportation brokers — payer-backed growth capital.

  • Modivcare / MTM incumbent

    Large NEMT brokers.

  • Medical Transportation Management incumbents incumbent

    Regional brokers.

  • Rideshare health products (Uber Health) adjacent

    On-demand rides without full NEMT benefit management.

Notable stories

  • SafeRide’s Series C pitch targeted the $10B+ NEMT market — arguing transportation is the last-mile barrier to life-sustaining care for MA/Medicaid members.

Industries

Healthtech Marketplaces

Related funding articles

Venture Capital Tracker pieces that cover SafeRide Health's financing or category context.

FAQs about SafeRide Health

Practical answers founders, operators, and investors typically search for.

Runs a technology platform and network for non-emergency medical transportation for Medicaid, Medicare Advantage, and providers.
Sands Capital led Series C (Oct 2023); Healthworx and SCAN participated.
San Antonio, Texas.
growth
No — private as of July 2026.
2016.
healthtech, marketplace
https://saferidehealth.com

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.